Micron Technology, Inc. vs Tenet Healthcare Corporation — how do they compare? Micron Technology, Inc. trades at $1,055.98 (market cap $1.23T), while Tenet Healthcare Corporation trades at $260 (market cap $20.92B). The key difference: Micron Technology, Inc. is far larger — about 58.8× Tenet Healthcare Corporation's market cap, and Micron Technology, Inc. pays a 0.06% dividend while Tenet Healthcare Corporation pays none. Which is the better fit depends on your goals — on Pluang, investors hold Micron Technology, Inc. for 48 Days and Tenet Healthcare Corporation for 15 Days on average.
| MU | THC | |
|---|---|---|
Market Cap | $1.23T | $20.92B |
Volume | 30,214,899 | 455,764 |
Sector | Technology | Health |
52-Week High | $1.21K | $280.77 |
52-Week Low | $181.60 | $161.37 |
Typical Hold Time | 48 Days | 15 Days |
Enterprise Value | $1.19T | $32.00B |
Dividend Yield | 0.06% | — |
Signals from Pluang's Aura AI — not financial advice
Micron Technology (MU) trades at $1,035.84, down 0.93% today but remains in a strong uptrend with a 500% gain over the past year. The stock exhibits bullish technical signals, supported by robust fundamentals including a 379% YoY revenue surge in fiscal 2026 and consistent earnings beats. Analyst sentiment is overwhelmingly positive, with 83% recommending Buy, citing AI-driven memory demand and strategic customer agreements securing future revenue.
Outlook: Micron is positioned for sustained growth through 2030 due to AI memory demand and supply constraints, but risks include cyclical slowdowns and valuation sensitivity. The consensus price target of $1,590 implies 53% upside, though high volatility and competitive pressures warrant caution for new investments.
Tenet Healthcare (THC) trades at $259.83, up 0.53% with strong technical momentum and bullish moving average signals. The company demonstrates robust fundamentals with consistent earnings beats (Q4 2025-Q2 2026), 82.83% gross margins, and 53.31% ROE. Recent news highlights strong cash flow supporting capital returns, with Q3 2026 results expected October 29, 2026.
THC presents compelling value with a 10.04 P/E ratio and 81.25% analyst buy ratings. Upside potential to $283.36 consensus target exists, though negative cash flow trends and insider selling warrant monitoring. The stock's premium valuation (P/B 4.49) requires sustained execution amid healthcare sector volatility.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Latest headlines on both assets
Micron historically focused on designing and manufacturing DRAM for PCs. The firm then expanded into the NAND flash memory market. It increased its DRAM scale with the purchase of Elpida (completed in mid-2013) and Inotera (completed in December 2016). The firm's DRAM and NAND products tailored to PCs, data centers, smartphones, game consoles, automotives, and other computing devices.
Read more on MU →Tenet Healthcare is a leading diversified healthcare services company that has strategically pivoted toward high-growth ambulatory care. Operating through United Surgical Partners International (USPI), the largest ambulatory platform in the U.S., Tenet manages an expansive network of surgical centers, acute care hospitals, and specialty facilities. The company’s focus on high-acuity services and operational efficiency, supported by its revenue cycle management subsidiary Conifer Health Solutions, positions it as a resilient leader in the evolving U.S. healthcare landscape.
Read more on THC →